Common diabetes drug tested in tiniest babies for lung protection
NCT ID NCT07120971
Summary
This early study is testing whether metformin, a medication commonly used for diabetes, is safe and well-tolerated in premature infants who have or are at high risk for a serious lung condition called bronchopulmonary dysplasia (BPD). Researchers will give different doses of the liquid medicine to 40 very premature babies to see how their bodies handle it and check for side effects. The main goal is to gather initial safety information to see if metformin could one day help protect and heal the lungs of these fragile infants.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BRONCHOPULMONARY DYSPLASIA (BPD) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Children's Wisconsin
RECRUITINGMilwaukee, Wisconsin, 53226, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.